SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-002051
Filing Date
2021-01-07
Accepted
2021-01-07 17:11:17
Documents
12
Period of Report
2021-01-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212046d1_8k.htm   iXBRL 8-K 27827
  Complete submission text file 0001104659-21-002051.txt   200885

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qure-20210104.xsd EX-101.SCH 3184
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20210104_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20210104_pre.xml EX-101.PRE 22709
5 EXTRACTED XBRL INSTANCE DOCUMENT tm212046d1_8k_htm.xml XML 3498
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 21514868
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences